Summary. In Exp. I, 0\m=.\5 mg oestradiol or vehicle (0\m=.\5 ml absolute ethanol + 0\m=.\5ml 0\m=.\9% NaCl) was injected i.v. at 08:00 h on Day 14 (onset of oestrus = Day 0). Blood samples were obtained via a jugular catheter at 30 and 1 min before oestradiol and every 30 min for 10 h afterwards. Plasma was obtained and assayed for 15-keto\x=req-\ 13,14-dihydro-PGF-2\g=a\(PGFM) by radioimmunoassay. Before (Barcikowski, Carlson, Wilson & McCracken, 1974) and oxytocin (Roberts, Barcikowski, Wilson, Skarnes & McCracken, 1975) induce premature luteolysis in nonpregnant ewes. However, doses of oestradiol which cause luteolysis in nonpregnant ewes are only partly effective in pregnant ewes (Kittock & Britt, 1977) . McCracken, Schramm & Okulicz (1984) developed the following general hypothesis to explain events leading to luteolysis in ewes. They proposed that oestradiol induces synthesis of oxytocin receptors which are inserted into the mem¬ brane of endometrial cells and that oxytocin binding activates, via activation of adenylate cyclase and cAMP, the arachidonic acid cascade and prostaglandin (PG) F-2a production. The PGF-2a is Reprint requests to Dr F. W. Bazer. the uterine luteolytic hormone in sheep. McCracken et al. (1984) and Zarco, Stabenfeldt, Kindahl, Bradford & Basu (1984) (Martal, Lacroix, Loudes, Saunier & Wintenberger-Torres, 1979; Godkin, Bazer, Thatcher & Roberts, 1984) . When proteins secreted by the sheep conceptus (Godkin et al., 1984) or conceptus homo¬ genates (Moor & Rowson, 1966; Martal et al., 1979) Godkin et al. (1984) . The medium from cultures was concentrated and dialysed extensively (1000 Mr cutoffdialysis tubing) against Dulbecco's phosphate-buffered saline (PBS, Dulbecco & Vogt, 1954) , pH 7-4 (6 litres changed four times). The preparation of conceptus secretory proteins (CSP) was filter-sterilized and supplemented with penicillin (200 U/ml), streptomycin (200 µg/ml) and fungizone (0 5µg/ml). The protein concentration was 0-4 mg/ml (Lowry, Rosebrough, Farr & Randall, 1951) .
Plasma protein from a Day-16 pregnant ewe was diluted to 0-4 mg/ml in MEM and prepared as described for CSP. Samples were stored at -20°C until used in Exp. II.
Hormone preparations. In Exps I and II, 100 mg oestradiol-17ß (Sigma Chemical Co., St Louis, MO, U.S.A.) were dissolved in 100 ml absolute ethanol and stored at 4°C. At the time of injection 500 µg oestradiol-17ß in 0-5 ml ethanol were mixed with 0-5 ml 0-9% (w/v) NaCl (vehicle) for injection via jugular catheter.
Oxytocin (Sigma) was dissolved in 0-9% (w/v) NaCl solution at 10 i.u./ml and 1 ml was injected via the jugular catheter on Day 15 in Exp. II. PGFM radioimmunoassay. Concentrations of PGFM in plasma were measured using a double-antibody RIA with a sensitivity of 50 pg/ml. Repetitive measurements of reference plasma (800 pg/ml) in duplicate among 10 assays were used to determine intrassay (Exp. I = 9-4%; Exp. II = 8-0%) and interassay (Exp. I = 15-2%; Exp. II = 71%) coefficients of variation. Crossreactivity of the antibody to PGFM with PGF-2a, PGE-2 and 6-keto PGF-2a was less than 1 % (Guilbault, Thatcher, Drost & Hopkins, 1984 Time was considered a continuous independent variable. Tests for homogeneity of regression were used to detect differences in PGFM response curves amongst treatment groups (Snedecor & Cochran, 1969) . Equality of variances were tested by 2 using the ratio of larger to smaller estimates of variance (Steel & Torrie, 1960 (Fig. la) concentrations of PGFM in plasma remained relatively constant during the 10-h sampling period. However, nonpregnant ewes treated with oestradiol responded with highly variable episodes of elevated PGFM 4-8 h after oestradiol injec¬ tion (148-1350 pg/ml) and in one ewe a second episode of elevated PGFM was detected at 9-5 h (Fig. lb) . Pregnant ewes treated with oestradiol did not respond with episodes of elevated PGFM, and only one ewe had PGFM concentrations that exceeded 200 pg/ml (Fig. lc) . The other ewes in that group maintained relatively constant PGFM concentrations (141 + 80 pg/ml).
There was heterogeneity of regression (P < 001) amongst PGFM responses of the three treat¬ ment groups. Injection of vehicle to pregnant ewes failed to induce a PGFM response compared to the two oestradiol-treated groups (P < 0-01). Injection of oestradiol induced a greater increase in PGFM in nonpregnant ewes; but, statistically significant differences between treatment groups were not detected because of the heterogeneity of variances. Nevertheless, pregnant ewes treated with oestradiol had less variable (P < 001) concentrations of PGFM. Data were transformed to natural logarithms and analysed. Again, heterogeneity of regression between the three treatment groups (P < 001) was detected. Tests for homogeneity of regression indicated, however, that PGFM response to oestradiol by pregnant ewes differed from that for nonpregnant ewes (P < 005). Experiment II Concentrations of PGFM in plasma were lower (P < 010) for CSP-treated ewes and there was a sampling time by treatment interaction (P < 0-01) indicating that changes in PGFM induced by oestradiol were different in CSP-and plasma protein-treated ewes (Fig. 2) . The ewes treated with plasma protein responded to oestradiol with episodes of elevated PGFM 4-8 h later, as for nonpregnant ewes in Exp. I, and the magnitude of PGFM response was again highly variable (mean + s.e.m., 1747 + 1339 pg/ml; range = 468-3764 pg/ml). The beginning of a second increase in PGFM was detected in 3 of 6 ewes when sampling was discontinued at 10 h after treatment. None of 6 CSP-treated ewes had PGFM concentrations that exceeded 750 pg/ml (mean + s.e.m., 595 + 123 pg/ml; range 397-747 pg/ml). Heterogeneity of regression (P < 001) in concentrations of PGFM between CSP-and plasma protein-treated ewes indicated that CSP altered the oestradiol-induced PGFM response.
Approximately 24 h after oestradiol injection (Day 15), CSP and plasma protein-treated ewes received injections of 10 i.u. oxytocin or 1 ml saline. A PGFM response was induced by injection of oxytocin (P < 010) and time of sampling by injection interaction (P < 001) was also detected (Fig. 3) . This interaction indicated that the response to saline was less than that for oxytocin. Peak PGFM response to oxytocin occurred at 30 min in each group. In the plasma protein-oxytocin group, peak PGFM (mean + s.e.m.) was 3972 + 2199 pg/ml and peak concentrations exceeded 3674 pg/ml in 2 of 3 ewes. The CSP-treated ewes had a less variable PGFM response (1669 + 287 pg/ml) and values did not exceed 2000 pg/ml. A protein (CSP vs plasma protein) by injection (oxytocin vs saline) interaction (P < 001) indicated that the PGFM response to oxytocin was greater in ewes treated with plasma protein than in those receiving CSP. In addition, interoestrous interval (mean + s.d.) was greater (P < 0-10) for CSP-treated (22 + 4 days) than for plasma protein-treated (18 + 2 days) ewes.
Discussion
The luteolytic effect of oestradiol (Barcikowski et al., 1974) and oxytocin (see Fairclough, Moore, Peterson & Watkins, 1984) late in the oestrous cycle of sheep has been demonstrated. However, oestradiol-induced release of uterine PGF is attenuated in the presence of the conceptus in the cow (Thatcher et ai, 1984) and ewe (Kittock & Britt, 1977) . In the ewe, the conceptus also attenuates oxytocin-induced production of PGF by the uterus (Fairclough et al., 1984) . Data from Exp. I indicated that pregnant ewes responded to oestradiol with reduced PGF release from the uterus compared to nonpregnant ewes. Five of 6 nonpregnant ewes responded to oestradiol with major episodes of PGF release 4-8 h after oestradiol. However, all pregnant ewes treated with oestradiol maintained relatively constant PGFM levels and no major episodes were detected. Basal PGFM concentrations, however, were higher in pregnant ewes, probably due to PGF production by the conceptus (Marcus, 1981) .
Data from Exp. I established a model of differential PGF release from the uterus by pregnant and nonpregnant ewes which allowed effects of CSP to be tested. The CSP were injected into non¬ pregnant uteri during the time when the conceptus 'signals' its presence to the maternal system (Moor & Rowson, 1966) . The PGFM response to oestradiol was suppressed in CSP-treated ewes, as in pregnancy (Exp. I). In addition, the PGFM response to oxytocin was suppressed in CSPtreated ewes, and mean interoestrous interval was extended despite the two potent hormonal challenges known to induce luteolysis in nonpregnant ewes. The ovine conceptus apparently pro¬ duces one or more proteins capable of suppressing PGF release by the endometrium, but site and mechanism of action of CSP have not been elucidated.
Ovine luteal tissue contains high concentrations of oxytocin (Wathes & Swann, 1982; Flint & Sheldrick, 1982a) and oxytocin receptors have been identified in ovine endometrium (Roberts, McCracken, Gavagan & Soloff, 1976) . Oxytocin is thought to be involved in stimulating normal luteal regression since: (1) active immunization against oxytocin delays luteolysis (Sheldrick & Flint, 1984; Schams, Prokopp & Schmidt-Adamopoulou, 1982) ; (2) peaks of oxytocin-associated neurophysin and PGF occur coincidentally late in the cycle (Fairclough et ai, 1980) ; and (3) exogenous administration of oxytocin induces luteolysis (Mitchell, Flint & Tumbull, 1975; Roberts et al., 1976) . Luteal secretion of oxytocin is stimulated by the PGF analogue, cloprostenol (Flint & Sheldrick, 1982b) ; therefore, CL regression may result from a systemic positive feedback loop involving initial secretion of PGF by the uterus and subsequent release of oxytocin from the CL which would reinforce PGF production by the uterus. Interruption in this mechanism may alter episodic release of PGF and allow extended corpus luteum function, while basal prostaglandin pro¬ duction may actually increase. Since basal PGFM concentrations are elevated during early preg¬ nancy according to present results and those of others (Wilson, Cenedella, Butcher & Inskeep, 1972; Ellinwood, Nett & Niswender, 1979) , interference~with uterine PGF secretion during ges¬ tation may not occur at the oxytocin receptor level. Alternatively, the production of PGF and PGE by the sheep conceptus may account for elevated basal values of PGFM in pregnant ewes.
The conceptus-produced proteins may alter enzymic conversion of intermediates in prosta¬ glandin biosynthesis, which may explain the increase in the ratio of PGE-2:PGF-2a reported for pregnant ewes between Days 13 and 15 (Silvia, Ottobre & Inskeep, 1984) . Prostaglandins E-2 and F-2a are derived from a common endoperoxide intermediate (Hamberg & Samuelsson, 1973) ; and driving synthesis toward one product therefore reduces levels of the other. The diversity of biologi¬ cal activities of the two prostaglandins (Horton, 1972; Hinman, 1972) suggests that physiological processes such as luteolysis could be efficiently controlled by stimulating enzymic pathways favouring high PGE-2:PGF-2a ratios.
The CSP may act on uterine endometrium to inhibit oestradiol and oxytocin-induced PGF pro¬ duction. The CSP probably do not affect PGF-2a production at the level of the oestradiol receptor, since many other oestradiol effects are required and have been observed throughout gestation (Catchpole, 1977) . However, the luteolytic effect of oestradiol is inhibited by infusion of CSP which is consistent with earlier reports for pregnant ewes (Kittock & Britt, 1977) and cows .
The conceptus proteins may also alter binding of oxytocin to its receptor. Suppression of oxytocin-induced PGFM response by CSP in Exp. II could be due to decreased oxytocin receptor numbers, as occurs in pregnant sheep (McCracken et al., 1984) , or to competitive binding of conceptus protein to the receptor. However, basal PGFM concentrations were elevated in Exp. I, perhaps due to conceptus PGF production, as reported previously (Marcus, 1981) . Therefore, it appears that the difference in response to oxytocin between CSP-and plasma protein-treated ewes is regulated at a point beyond the receptor level, perhaps through differences in activity of enzymes affecting synthesis and/or metabolism of prostaglandins. Zarco et al. (1984) reported that the mean number of PGFM pulses per 25 h in nonpregnant ewes was 5-5 compared to only 1-3 in pregnant ewes, although PGE-2 increases dramatically between Days 13 and 15 of pregnancy (Silvia et al., 1984) . It is possible that PGF-2a is readily con¬ verted to PGE-2 in the presence of oxidized cofactors (Lee & Levine, 1974) 
